Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H11Br2N5O |
InChIKeyCLFRUTTXUXBVGI-UHFFFAOYSA-N |
CAS Registry2703869-93-4 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | France | 08 Jan 2021 |





